Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Cisplatin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Central Nervous System Neoplasms 27 Neuroblastoma 25 Brain Neoplasms 20 Medulloblastoma 17 Astrocytoma 8 Glioma 7 Glioblastoma 6 Breast Neoplasms 6 Neoplasms 5 Ependymoma 5 Choroid Plexus Neoplasms 5 Sarcoma 4 Oligodendroglioma 4 Neuroectodermal Tumors, Primitive 4 Ganglioneuroblastoma 4 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Gliosarcoma 3 Esthesioneuroblastoma, Olfactory 3 Testicular Neoplasms 2 Testicular Germ Cell Tumor 2 Teratoma 2 Spinal Cord Neoplasms 2 Small Cell Lung Carcinoma 2 Seminoma 2 Melanoma 2 Endodermal Sinus Tumor 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2

Interventions

Temozolomide 2 vorasidenib 1 pembrolizumab 1 pamiparib 1 cixutumumab 1 Vorinostat 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Antibodies, Monoclonal 1 Aminolevulinic Acid 1 Amifostine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡